(Q44324361)

English

Evaluation of vascular endothelial growth factor blockade and matrix metalloproteinase inhibition as a combination therapy for experimental human pancreatic cancer

scientific article published in February 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Evaluation of vascular endothelial growth factor blockade and matrix metalloproteinase inhibition as a combination therapy for experimental human pancreatic cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

0 references

author name string

Hubert G Hotz

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

O Joe Hines

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Birgit Hotz

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Thomas Foitzik

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Heinz J Buhr

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Howard A Reber

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

publication date

1 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Journal of Gastrointestinal Surgery

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

220-7; discussion 227-8

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

https://scigraph.springernature.com/pub.10.1016/s1091-255x(02)00157-9

0 references

The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential localization of human pancreas cancer-associated antigen and carcinoembryonic antigen in homologous pancreatic tumoral xenograft.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase (MMP) inhibition selectively decreases type II MMP activity in a murine model of pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The contribution of proangiogenic factors to the progression of malignant disease: role of vascular endothelial growth factor and its receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The regulation of neovascularization of matrix metalloproteinases and their inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Batimastat, a potent matrix mealloproteinase inhibitor, exhibits an unexpected mode of binding

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The matrix metalloproteinases and their inhibitors in pancreatic cancer. From molecular science to a clinical application

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An improved clinical model of orthotopic pancreatic cancer in immunocompetent Lewis rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase inhibition suppresses MMP-2 activity and activation of PANC-1 cells in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-angiogenesis: new concept for therapy of solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VEGF antisense therapy inhibits tumor growth and improves survival in experimental pancreatic cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical development of metalloproteasis inhibitors in cancer therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9)

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinases: pro- and anti-angiogenic activities

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intratumor microvessel density as a prognostic factor in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase inhibition improves survival in an orthotopic model of human pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase inhibition attenuates human pancreatic cancer growth in vitro and decreases mortality and tumorigenesis in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy in the treatment of cancer of the pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of matrix metalloproteinase inhibition on pancreatic cancer invasion and metastasis: an additive strategy for cancer control

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Addition of matrix metalloproteinase inhibition to conventional cytotoxic therapy reduces tumor implantation and prolongs survival in a murine model of human pancreatic cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific targeting of tumor vasculature by diphtheria toxin-vascular endothelial growth factor fusion protein reduces angiogenesis and growth of pancreatic cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor (VEGF) and its receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitory effect of a matrix metalloproteinase inhibitor on growth and spread of human pancreatic ductal adenocarcinoma evaluated in an orthotopic severe combined immunodeficient (SCID) mouse model

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic carcinoma in perspective. A continuing challenge

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resection of pancreatic cancer--surgical achievements.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Animal models of exocrine pancreatic cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12600446

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S1091-255X(02)00157-9

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44324361&oldid=2142229598"